Efficient and Specific In Vivo Genetic Engineering of Human Hematopoietic Stem Progenitor Cells without Selective Conditioning

Achieving in vivo genetic engineering of hematopoietic stem progenitor cells (HSPC) has the potential to transform treatment for hematological disorders. An ideal in vivo delivery platform should provide access to resting HSPC at low doses, in different in vivo compartments and with high specificity...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.2252-2252
Hauptverfasser:	Botchkarev, Vladimir V, Harrington, Sean, Justen, Alexander, Kimber, Casey, Kapuria, Anjali, Xu, Yuanxin, Haugh, Kelsey, Ankala, Ramya, Kipniss, Nathan, de Jesus, Rowena, Adewale, Funmi, Daniels, Kathy, Crocker, Samantha, Liang, Anna, Joyce, Shannon, Smith, Derek, Wong, Athena, Berlfein, Valeria, Amatya, Shirisha, Cruite, Patricia, Usmani, Shariq, Ruzo, Albert, Ferland, Benjamin, Chandra, Sundeep, Stoppato, Matteo, Trudeau, Kyle, Rebar, Edward, Shah, Jagesh, Biasco, Luca
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!